Stay updated on Pembrolizumab and Radiation in Cancer of Unknown Primary Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Radiation in Cancer of Unknown Primary Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Radiation in Cancer of Unknown Primary Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The ClinicalTrials.gov page's footer displays an updated site revision label, from v3.8.0 to v3.8.1.
    Difference
    0.1%
    Check dated 2026-11-18T01:15:53.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The clinical trial record for pembrolizumab with concurrent radiation in previously treated carcinoma of unknown primary is displayed, including its study details, participation criteria, and results-related information.
    Difference
    56%
    Check dated 2026-11-10T20:37:07.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-11-03T21:28:44.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a terminology transition from “Artificial Intelligence” to “Super Intelligence,” and the site revision label updates from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T20:57:06.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-06T20:41:50.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The study page now renders a 403 Forbidden error with HTML indicating restricted access, and the visible study content appears removed or hidden as a result.
    Difference
    20%
    Check dated 2026-09-22T22:45:32.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Radiation in Cancer of Unknown Primary Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Radiation in Cancer of Unknown Primary Clinical Trial page.